We are proud to work with experienced professionals who are willing to share their knowledge, confirming the expert position of Polpharma API on the market.
Tomorrow, on Thursday, October 22, Adam Hałuszczuk, the leader of the group responsible for risk management related to the presence of nitrosamines in active substances at Polpharma, will conduct a webinar on EMA and FDA requirements for the pharmaceutical industry. You will find out at what stage we are and what solutions we implement for our active substances.
A week later, on October 29, Dorota Pogoda, Head of the Solid State Chemistry Group, will tell you why the particle size of active substances is so important in the pharmaceutical sector and what solutions are offered by Polpharma API.
Both webinars will be held at 2 p.m. and will be conducted in English. We invite you to sign up:
